Loading…

Medium chain fatty acid ethyl esters - activation of antimicrobial effects by Malassezia enzymes

Summary Free medium and short chain fatty acids are known to have broad antimicrobial activity. However, their practical use in topical therapy is limited by their intensive smell and acidity. Surprisingly, a nearly identical antimicrobial effect was found with the ethyl ester derivatives of these f...

Full description

Saved in:
Bibliographic Details
Published in:Mycoses 2015-04, Vol.58 (4), p.215-219
Main Author: Mayser, Peter
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4660-5e76392a1ef0a9b5aeedf8aedb05e14c9afc09d62864f9250cd1b8b38a067ab83
cites cdi_FETCH-LOGICAL-c4660-5e76392a1ef0a9b5aeedf8aedb05e14c9afc09d62864f9250cd1b8b38a067ab83
container_end_page 219
container_issue 4
container_start_page 215
container_title Mycoses
container_volume 58
creator Mayser, Peter
description Summary Free medium and short chain fatty acids are known to have broad antimicrobial activity. However, their practical use in topical therapy is limited by their intensive smell and acidity. Surprisingly, a nearly identical antimicrobial effect was found with the ethyl ester derivatives of these fatty acids, but only against Malassezia (M.) yeast, not against Candida spp. Obviously, these esters are hydrolysed by M. enzymes, thus generating a selective activation of antimicrobial activity especially in areas well populated with these yeast (‘targeting’). Octanoic acid ethyl ester (CAS 106‐32‐1) was found to be most suitable. In an agar dilution test, the minimal inhibitory concentrations against M. globosa, M. pachydermatis and M. sympodialis, respectively, ranged between ~5 and 10 mmol l−1 after 10 days of incubation. The effect started immediately and was not delayed by other lipid sources applied simultaneously. Based on these data, fatty acid monoesters may represent a new therapeutic concept in M.‐associated diseases.
doi_str_mv 10.1111/myc.12300
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1668259447</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1668259447</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4660-5e76392a1ef0a9b5aeedf8aedb05e14c9afc09d62864f9250cd1b8b38a067ab83</originalsourceid><addsrcrecordid>eNqNkUtPFUEQhTtEA1dk4R8wvdTFQL-me3ppbhRMuJIQ1OimqempDg3zwOm54PDrbbjAjsTaVFL5zknVKULecbbPcx10s9_nQjK2RRZcSVuwkplXZMGslIVRzOyQNyldMsaNFXqb7IhSG82MWpDzFTZx3VF_AbGnAaZppuBjQ3G6mFuKacIx0SLPpngDUxx6OgQK_RS76MehjpChENBPidYzXUELKeFdBIr93dxhekteB2gT7j32XfL9y-ez5VFxfHL4dfnpuPBKa1aUaLS0AjgGBrYuAbEJFWBTsxK58haCZ7bRotIqWFEy3_C6qmUFTBuoK7lLPmx8r8fhzzrv7bqYPLYt9Disk-NaV6K0Spn_QZXg0hqZ0Y8bNN-a0ojBXY-xg3F2nLn77F3O3j1kn9n3j7brusPmmXwKOwMHG-A2tji_7ORWv5ZPlsVGEfMf_j4rYLxy2khTup_fDt3vox-rU26EW8p_vGOdnA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1664213973</pqid></control><display><type>article</type><title>Medium chain fatty acid ethyl esters - activation of antimicrobial effects by Malassezia enzymes</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Mayser, Peter</creator><creatorcontrib>Mayser, Peter</creatorcontrib><description>Summary Free medium and short chain fatty acids are known to have broad antimicrobial activity. However, their practical use in topical therapy is limited by their intensive smell and acidity. Surprisingly, a nearly identical antimicrobial effect was found with the ethyl ester derivatives of these fatty acids, but only against Malassezia (M.) yeast, not against Candida spp. Obviously, these esters are hydrolysed by M. enzymes, thus generating a selective activation of antimicrobial activity especially in areas well populated with these yeast (‘targeting’). Octanoic acid ethyl ester (CAS 106‐32‐1) was found to be most suitable. In an agar dilution test, the minimal inhibitory concentrations against M. globosa, M. pachydermatis and M. sympodialis, respectively, ranged between ~5 and 10 mmol l−1 after 10 days of incubation. The effect started immediately and was not delayed by other lipid sources applied simultaneously. Based on these data, fatty acid monoesters may represent a new therapeutic concept in M.‐associated diseases.</description><identifier>ISSN: 0933-7407</identifier><identifier>EISSN: 1439-0507</identifier><identifier>DOI: 10.1111/myc.12300</identifier><identifier>PMID: 25676074</identifier><language>eng</language><publisher>Germany: Blackwell Publishing Ltd</publisher><subject>Antifungal Agents - pharmacology ; antimicrobial effects ; atopic dermatitis ; Candida ; Candida - drug effects ; Caprylates - pharmacology ; Chromatography, Thin Layer ; Esters - pharmacology ; ethyl esters ; Fatty Acids - pharmacology ; hydrolytic activity ; Malassezia ; Malassezia - drug effects ; Malassezia - enzymology ; Malassezia spp ; Microbial Sensitivity Tests ; Saccharomyces cerevisiae - drug effects ; targeting</subject><ispartof>Mycoses, 2015-04, Vol.58 (4), p.215-219</ispartof><rights>2015 Blackwell Verlag GmbH</rights><rights>2015 Blackwell Verlag GmbH.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4660-5e76392a1ef0a9b5aeedf8aedb05e14c9afc09d62864f9250cd1b8b38a067ab83</citedby><cites>FETCH-LOGICAL-c4660-5e76392a1ef0a9b5aeedf8aedb05e14c9afc09d62864f9250cd1b8b38a067ab83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25676074$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mayser, Peter</creatorcontrib><title>Medium chain fatty acid ethyl esters - activation of antimicrobial effects by Malassezia enzymes</title><title>Mycoses</title><addtitle>Mycoses</addtitle><description>Summary Free medium and short chain fatty acids are known to have broad antimicrobial activity. However, their practical use in topical therapy is limited by their intensive smell and acidity. Surprisingly, a nearly identical antimicrobial effect was found with the ethyl ester derivatives of these fatty acids, but only against Malassezia (M.) yeast, not against Candida spp. Obviously, these esters are hydrolysed by M. enzymes, thus generating a selective activation of antimicrobial activity especially in areas well populated with these yeast (‘targeting’). Octanoic acid ethyl ester (CAS 106‐32‐1) was found to be most suitable. In an agar dilution test, the minimal inhibitory concentrations against M. globosa, M. pachydermatis and M. sympodialis, respectively, ranged between ~5 and 10 mmol l−1 after 10 days of incubation. The effect started immediately and was not delayed by other lipid sources applied simultaneously. Based on these data, fatty acid monoesters may represent a new therapeutic concept in M.‐associated diseases.</description><subject>Antifungal Agents - pharmacology</subject><subject>antimicrobial effects</subject><subject>atopic dermatitis</subject><subject>Candida</subject><subject>Candida - drug effects</subject><subject>Caprylates - pharmacology</subject><subject>Chromatography, Thin Layer</subject><subject>Esters - pharmacology</subject><subject>ethyl esters</subject><subject>Fatty Acids - pharmacology</subject><subject>hydrolytic activity</subject><subject>Malassezia</subject><subject>Malassezia - drug effects</subject><subject>Malassezia - enzymology</subject><subject>Malassezia spp</subject><subject>Microbial Sensitivity Tests</subject><subject>Saccharomyces cerevisiae - drug effects</subject><subject>targeting</subject><issn>0933-7407</issn><issn>1439-0507</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqNkUtPFUEQhTtEA1dk4R8wvdTFQL-me3ppbhRMuJIQ1OimqempDg3zwOm54PDrbbjAjsTaVFL5zknVKULecbbPcx10s9_nQjK2RRZcSVuwkplXZMGslIVRzOyQNyldMsaNFXqb7IhSG82MWpDzFTZx3VF_AbGnAaZppuBjQ3G6mFuKacIx0SLPpngDUxx6OgQK_RS76MehjpChENBPidYzXUELKeFdBIr93dxhekteB2gT7j32XfL9y-ez5VFxfHL4dfnpuPBKa1aUaLS0AjgGBrYuAbEJFWBTsxK58haCZ7bRotIqWFEy3_C6qmUFTBuoK7lLPmx8r8fhzzrv7bqYPLYt9Disk-NaV6K0Spn_QZXg0hqZ0Y8bNN-a0ojBXY-xg3F2nLn77F3O3j1kn9n3j7brusPmmXwKOwMHG-A2tji_7ORWv5ZPlsVGEfMf_j4rYLxy2khTup_fDt3vox-rU26EW8p_vGOdnA</recordid><startdate>201504</startdate><enddate>201504</enddate><creator>Mayser, Peter</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>M7N</scope></search><sort><creationdate>201504</creationdate><title>Medium chain fatty acid ethyl esters - activation of antimicrobial effects by Malassezia enzymes</title><author>Mayser, Peter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4660-5e76392a1ef0a9b5aeedf8aedb05e14c9afc09d62864f9250cd1b8b38a067ab83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Antifungal Agents - pharmacology</topic><topic>antimicrobial effects</topic><topic>atopic dermatitis</topic><topic>Candida</topic><topic>Candida - drug effects</topic><topic>Caprylates - pharmacology</topic><topic>Chromatography, Thin Layer</topic><topic>Esters - pharmacology</topic><topic>ethyl esters</topic><topic>Fatty Acids - pharmacology</topic><topic>hydrolytic activity</topic><topic>Malassezia</topic><topic>Malassezia - drug effects</topic><topic>Malassezia - enzymology</topic><topic>Malassezia spp</topic><topic>Microbial Sensitivity Tests</topic><topic>Saccharomyces cerevisiae - drug effects</topic><topic>targeting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mayser, Peter</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><jtitle>Mycoses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mayser, Peter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Medium chain fatty acid ethyl esters - activation of antimicrobial effects by Malassezia enzymes</atitle><jtitle>Mycoses</jtitle><addtitle>Mycoses</addtitle><date>2015-04</date><risdate>2015</risdate><volume>58</volume><issue>4</issue><spage>215</spage><epage>219</epage><pages>215-219</pages><issn>0933-7407</issn><eissn>1439-0507</eissn><abstract>Summary Free medium and short chain fatty acids are known to have broad antimicrobial activity. However, their practical use in topical therapy is limited by their intensive smell and acidity. Surprisingly, a nearly identical antimicrobial effect was found with the ethyl ester derivatives of these fatty acids, but only against Malassezia (M.) yeast, not against Candida spp. Obviously, these esters are hydrolysed by M. enzymes, thus generating a selective activation of antimicrobial activity especially in areas well populated with these yeast (‘targeting’). Octanoic acid ethyl ester (CAS 106‐32‐1) was found to be most suitable. In an agar dilution test, the minimal inhibitory concentrations against M. globosa, M. pachydermatis and M. sympodialis, respectively, ranged between ~5 and 10 mmol l−1 after 10 days of incubation. The effect started immediately and was not delayed by other lipid sources applied simultaneously. Based on these data, fatty acid monoesters may represent a new therapeutic concept in M.‐associated diseases.</abstract><cop>Germany</cop><pub>Blackwell Publishing Ltd</pub><pmid>25676074</pmid><doi>10.1111/myc.12300</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0933-7407
ispartof Mycoses, 2015-04, Vol.58 (4), p.215-219
issn 0933-7407
1439-0507
language eng
recordid cdi_proquest_miscellaneous_1668259447
source Wiley-Blackwell Read & Publish Collection
subjects Antifungal Agents - pharmacology
antimicrobial effects
atopic dermatitis
Candida
Candida - drug effects
Caprylates - pharmacology
Chromatography, Thin Layer
Esters - pharmacology
ethyl esters
Fatty Acids - pharmacology
hydrolytic activity
Malassezia
Malassezia - drug effects
Malassezia - enzymology
Malassezia spp
Microbial Sensitivity Tests
Saccharomyces cerevisiae - drug effects
targeting
title Medium chain fatty acid ethyl esters - activation of antimicrobial effects by Malassezia enzymes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T21%3A22%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Medium%20chain%20fatty%20acid%20ethyl%20esters%20-%20activation%20of%20antimicrobial%20effects%20by%20Malassezia%20enzymes&rft.jtitle=Mycoses&rft.au=Mayser,%20Peter&rft.date=2015-04&rft.volume=58&rft.issue=4&rft.spage=215&rft.epage=219&rft.pages=215-219&rft.issn=0933-7407&rft.eissn=1439-0507&rft_id=info:doi/10.1111/myc.12300&rft_dat=%3Cproquest_cross%3E1668259447%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4660-5e76392a1ef0a9b5aeedf8aedb05e14c9afc09d62864f9250cd1b8b38a067ab83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1664213973&rft_id=info:pmid/25676074&rfr_iscdi=true